This study tests a drug called Gleolan that makes ovarian cancer cells glow during surgery. The goal is to help surgeons find and remove tumors they might otherwise miss. About 170 women with suspected or recurrent ovarian cancer will take part. The study lasts about two weeks pe…
Phase: PHASE3 • Sponsor: NX Development Corp • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC